Subsequent studies on Gal3 inhibition showed that Gal3 knockout or administration of a Gal3 inhibitor significantly improved levels of insulin resistance in obese mice, suggesting Gal3 as a potential drug target related to treatment of insulin resistance and diabetes. The gene discussed is LGALS3; the disease is Insulin resistance.